Partnership / Collaboration · GCC · Announced 8 Oct 2026

Sana Pharma → National Pharmaceutical Industries

Partnership / Collaboration deal between Sana Pharma (Jordan) and National Pharmaceutical Industries (Oman), announced 8 Oct 2026.

Parties: Sana Pharma (Jordan) → National Pharmaceutical Industries Co. (NPI, Oman) (Oman)

Value
Not stated
Territory
Oman / Jordan bilateral
Therapeutic area
Multi-therapy
Announced
8 Oct 2026

Our analysis

Why this matters

This is the lowest-capex, fastest form of technology transfer in the industry — a dossier swap. NPI is one of Oman's most proven exporters (est. 2001, RO 35M cumulative investment, exports to 45+ countries including the US and Europe per ONA).

Dossier exchange gives NPI ready-made product files for its export markets and gives Jordan's Sana Pharma Omani manufacturing capacity behind them — no greenfield, no equity, pure regulatory asset arbitrage.

The full analysis is free to read with a work email on this page.

Source: ONA / Muscat Daily

Latest deals

All GCC deals → · All partnership / collaboration deals → · Browse all emerging-market pharma deals →